Retail Giants Accuse Takeda of Antitrust Violations Over Delayed Generic Dexilant Release

In a recent legal development, Walgreens, Kroger, Albertsons, and H-E-B have filed an antitrust lawsuit against Takeda and TWi Pharmaceuticals. The suit, lodged in a California federal court, accuses the pharmaceutical companies of allegedly conspiring to delay the release of the generic version of Dexilant, a heartburn medication. The delay purportedly forced the retailers to continue purchasing the more expensive brand-name drug, increasing their costs. For further details on the lawsuit, click here.